Neocor Therapeutics
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$940,000
Company Overview
Neocor Therapeutics is a biotechnology company that is developing a novel gene therapy approach for cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neocor Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Neocor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Pre Seed | Dec 1, 2023 |
Neocor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Sud-Est | Grant |
| Bpifrance | Grant |
| Crédit Agricole Alpes Provence | Pre Seed |
| Incubateur Impulse | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
$431K grant received from Bpifrance.
- Jan 1, 2024
$437K grant received from SATT Sud-Est.
Neocor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neocor Therapeutics's valuation, stock price, and market status.
